Financial Year |
March 31 2023 |
Monetary Funds |
2,216,936,866.36 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
4,736,268.21 |
Accounts Receivable |
1,111,593,963.24 |
Advances to Suppliers |
26,728,467.32 |
Other Receivables |
143,050,867.74 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
995,354,012.49 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
22,446,261.42 |
Total Current Assets |
4,566,071,588.57 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
17,041,638.22 |
Investment Properties |
-- |
Fixed Assetes |
209,182,994.58 |
Under-construction Projects |
97,920,354.91 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
606,976,080.22 |
R&D expenses |
103,360,181.33 |
Goodwill |
1,003,737,212.80 |
Long-Term Deferred and Prepaid Expenses |
5,616,507.15 |
Deferred Income Tax Assets |
223,249,568.88 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
2,487,107,334.20 |
Total Assets |
7,053,178,922.77 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
500,502,277.73 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
32,735,519.68 |
Taxes Payable |
6,006,958.87 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
112,465,461.85 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
13,119,728.32 |
Other Current Liabilities |
3,860,910.24 |
Sub-Total of Current Liabilities |
1,321,484,479.57 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
5,362,726.55 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
29,545,484.88 |
Total Liabilities |
1,351,029,964.45 |
Paid-In Capital(Or Share Stock) |
824,561,023.00 |
Capital Surplus |
3,282,745,034.25 |
Surplus Reserve |
102,450,598.17 |
LESS:Treasury Stock |
132,418,759.75 |
Undistributed Profits |
1,518,508,823.39 |
Minority Stockholder's Interest |
120,872,339.26 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,581,276,619.06 |
Owner's Equity(Stockholder's Equity) |
5,702,148,958.32 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
7,053,178,922.77 |